remote patient monitoring

Devices, Technology January 28, 2020

BioIntelliSense Announces FDA Clearance of the BioSticker™, the First Single-Use Medical Device Enabling 30 Days of Continuous Vital Signs Monitoring

An effortless patient experience combined with actionable clinical intelligence to bring medical-grade care to the home BioIntelliSense, Inc., a continuous health monitoring and clinical intelligence company, today announces the U.S. commercial launch of its medical…

Business, Partnerships June 26, 2019

Varian to Provide Mobile Technology to Cancer Patients Across Tennessee

Collaboration with Tennessee Oncology Aims to Improve Access to Care Across Rural Patient Populations Providing cancer patients an opportunity for increased participation in their treatment, Varian (NYSE: VAR) today announced its collaboration with Tennessee Oncology for the implementation…